It Takes a Village: Providing International Pediatric Pathology Services in a Resource-Limited Setting

Amanda M Hopp1,2, Julie E Tetzlaff1,2, Kyle Kopidlansky1

  • 1Department of Pathology, Children's Wisconsin, Milwaukee, WI, USA.

Insights

Pathology partnerships between low-income (LMIC) and high-income countries (HIC) improve diagnostics. A collaboration between Angkor Hospital for Children and Children's Wisconsin demonstrated significant impact on patient management through remote pathology interpretations.

Area of Science:

  • Global Health
  • Medical Diagnostics
  • International Collaboration

Background:

  • Health disparities persist between low- to middle-income countries (LMICs) and high-income countries (HICs).
  • Limited healthcare resources, including pathology services, in LMICs like Cambodia's Angkor Hospital for Children (AHC) exacerbate these disparities.
  • Partnerships between LMICs and HICs offer a strategy to address these inequities.

Purpose of the Study:

  • To describe the established pathology workflow in a partnership between AHC (LMIC) and Children's Wisconsin (CW, HIC).
  • To examine pathology cases from AHC patients interpreted by CW.
  • To evaluate the impact of CW's pathology interpretations on patient management at AHC.

Main Methods:

  • AHC provided clinical information and shipped specimens to CW for processing and interpretation.
  • Pathology reports were electronically transmitted from CW to AHC.
  • Diagnoses were categorized as concordant, refined, or discordant; management changes were tracked.

Main Results:

  • 347 specimens were analyzed (177 malignant, 146 benign, 24 insufficient).
  • 31% of diagnoses were discordant with the initial clinical impression.
  • CW's interpretations led to a change in management for 44% of cases with clinical follow-up.

Conclusions:

  • Integrating pathology services into LMIC-HIC partnerships is vital for reducing health disparities.
  • The described pathology workflow is adaptable to various institutional needs and resource levels.
  • Such collaborations enhance diagnostic capabilities and patient care in resource-limited settings.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.6K